Study Summary
This trial will help create a questionnaire to confirm relapses in MS patients and study if communication with providers improves patient care.
Treatment Effectiveness
Phase-Based Effectiveness
Study Objectives
1 Primary · 0 Secondary · Reporting Duration: 96 weeks
Trial Safety
Phase-Based Safety
Awards & Highlights
Trial Design
2 Treatment Groups
Control
1 of 2
Experimental
1 of 2
Active Control
Experimental Treatment
150 Total Participants · 2 Treatment Groups
Primary Treatment: Communication with the clinic · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 4 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
To what extent is this research trial recruiting participants?
"Affirmative. The information hosted on clinicaltrials.gov establishes that this medical experiment, which was initially posted on July 31st 2018 is currently recruiting patients. 150 participants must be recruited from a single study site." - Anonymous Online Contributor
Is it still possible to participate in this research endeavor?
"Affirmative. On clinicaltrials.gov, it is noted that this examination commenced its recruitment of participants on July 31st 2018 and was last modified on May 5th 2022. The trial aims to enlist 150 individuals from a single medical location." - Anonymous Online Contributor